ABCL
Price
$5.31
Change
-$0.36 (-6.35%)
Updated
Jul 24 closing price
Capitalization
1.62B
11 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$2.96
Change
-$0.05 (-1.66%)
Updated
Jul 24 closing price
Capitalization
1.57B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs RXRX

ABCL vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. RXRX commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (ABCL: $5.31 vs. RXRX: $3.01)
Brand notoriety: ABCL and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 43% vs. RXRX: 66%
Market capitalization -- ABCL: $1.62B vs. RXRX: $1.57B
ABCL [@Biotechnology] is valued at $1.62B. RXRX’s [@Biotechnology] market capitalization is $1.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ABCL is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 6 bearish.
  • RXRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -17.87% price change this week, while RXRX (@Biotechnology) price change was -0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 05, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.62B) and RXRX($1.57B) have the same market capitalization . ABCL YTD gains are higher at: 55.263 vs. RXRX (-26.406). ABCL has higher annual earnings (EBITDA): -167.02M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. ABCL (505M). RXRX has less debt than ABCL: RXRX (72.4M) vs ABCL (140M). ABCL has higher revenues than RXRX: ABCL (79.2M) vs RXRX (65.7M).
ABCLRXRXABCL / RXRX
Capitalization1.62B1.57B103%
EBITDA-167.02M-478.66M35%
Gain YTD55.263-26.406-209%
P/E RatioN/AN/A-
Revenue79.2M65.7M121%
Total Cash505M654M77%
Total Debt140M72.4M193%
TECHNICAL ANALYSIS
Technical Analysis
ABCLRXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 29 days ago
80%
Bullish Trend 29 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ESLV28.630.06
+0.22%
Eventide Large Cap Value ETF
DMXF84.51N/A
N/A
iShares ESG Advanced MSCI EAFE ETF
GJH9.45-0.03
-0.31%
Synthetic Fixed-Income Sec STRATS 2004-06
MTUL56.86-0.31
-0.54%
ETRACS 2x Lvrgd MSCI US Mntm Fctr TR ETN
ATFV38.20-0.37
-0.96%
Alger 35 ETF

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with ABCL. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+1.01%
ABCL - RXRX
63%
Loosely correlated
-1.05%
PRME - RXRX
61%
Loosely correlated
-3.88%
CRSP - RXRX
61%
Loosely correlated
+0.61%
ABSI - RXRX
58%
Loosely correlated
-2.06%
BEAM - RXRX
56%
Loosely correlated
-2.74%
More